{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T02:54:25Z","timestamp":1719197665592},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.remn.2016.11.005","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T13:30:38Z","timestamp":1487338238000},"page":"227-232","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Valor de la PET\/TC cerebral con 18 F-fluorocolina en la detecci\u00f3n de recurrencias de neoplasias primarias del sistema nervioso central"],"prefix":"10.1016","volume":"36","author":[{"given":"A.","family":"Montes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"de Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Craven-Bartle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Molet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"G\u00f3mez-Ans\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Carri\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2016.11.005_bib0150","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/jnci\/djr077","article-title":"Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system","volume":"103","author":"Kohler","year":"2011","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.remn.2016.11.005_bib0155","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00259-014-2971-8","article-title":"Imaging biomarkers in primary brain tumours","volume":"42","author":"Lopci","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2016.11.005_bib0160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","article-title":"Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas","volume":"9","author":"Brandsma","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.remn.2016.11.005_bib0165","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00259-009-1302-y","article-title":"Clinical impact of 11C methionine PET on expected management of patients with brain neoplasm","volume":"37","author":"Yamane","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2016.11.005_bib0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF02984466","article-title":"Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery\u2013in malignant glioma","volume":"18","author":"Tsuyuguchi","year":"2004","journal-title":"Ann Nucl Med."},{"key":"10.1016\/j.remn.2016.11.005_bib0175","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3171\/jns.2001.95.5.0746","article-title":"Positron emission tomography with injection of methionine as a prognostic factor in glioma","volume":"95","author":"De Witte","year":"2001","journal-title":"J Neurosurg."},{"key":"10.1016\/j.remn.2016.11.005_bib0180","first-page":"173","article-title":"New PET radiopharmaceuticals beyond FDG for brain tumor imaging","volume":"56","author":"Guly\u00e0s","year":"2012","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2016.11.005_bib0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2967\/jnumed.111.096859","article-title":"Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: A systematic review and metaanalysis","volume":"53","author":"Dunet","year":"2012","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2016.11.005_bib0190","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00259-003-1259-1","article-title":"Brain tumour imaging with PET: A comparison between [18F]fluorodopa and [11C]methionine","volume":"30","author":"Becherer","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2016.11.005_bib0195","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiol.2223010558","article-title":"High grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR imaging","volume":"222","author":"Law","year":"2002","journal-title":"Radiology."},{"key":"10.1016\/j.remn.2016.11.005_bib0200","first-page":"4630","article-title":"Immortalization and transformation are associated with specific alterations in choline metabolism","volume":"56","author":"Bhakoo","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.remn.2016.11.005_bib0205","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00259-015-2997-6","article-title":"18F-Fluorocholine PET\/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility","volume":"42","author":"G\u00f3mez-R\u00edo","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2016.11.005_bib0210","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00259-005-0045-7","article-title":"Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L-tyrosine and 18Ffluoro-2-deoxyglucose in F98 gliomas in the rat","volume":"33","author":"Spaeth","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2016.11.005_bib0215","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2967\/jnumed.106.036251","article-title":"Uptake of 18FFluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP (L19), a marker of angiogenesis","volume":"48","author":"Wyss","year":"2007","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2016.11.005_bib0220","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s00259-009-1101-5","article-title":"Influence of multidrug resistance on (18)F-FCH cellular uptake in a glioblastoma model","volume":"36","author":"Vanpouille","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2016.11.005_bib0225","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.nucmedbio.2011.10.003","article-title":"11CCho PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas","volume":"39","author":"Li","year":"2012","journal-title":"Nucl Med Biol."},{"key":"10.1016\/j.remn.2016.11.005_bib0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/1381612820666140915120742","article-title":"Clinical Applications of Choline PET\/CT in Brain Tumors","volume":"21","author":"Giovannini","year":"2015","journal-title":"Curr Pharm Des."},{"key":"10.1016\/j.remn.2016.11.005_bib0235","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2176\/nmc.oa2013-0117","article-title":"Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis","volume":"54","author":"Takenaka","year":"2014","journal-title":"Neurol Med Chir (Tokyo)."},{"key":"10.1016\/j.remn.2016.11.005_bib0240","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00259-012-2295-5","article-title":"Value of 11C-methionine PET in imaging brain tumours and metastases","volume":"40","author":"Glaudemans","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2016.11.005_bib0245","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1097\/RLU.0b013e31824c5dd0","article-title":"Distribution patterns of 18F-labelled fluoromethylcholine in normal structures and tumors of the head: A PET\/MRI evaluation","volume":"37","author":"Mertens","year":"2012","journal-title":"Clin Nucl Med."},{"key":"10.1016\/j.remn.2016.11.005_bib0250","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/MNM.0b013e328355b6f5","article-title":"The optimal timing for imaging brain tumours and other brain lesions with 18F-labelled fluoromethylcholine: A dynamic positron emission tomography study","volume":"33","author":"Mertens","year":"2012","journal-title":"Nucl Med Commun."},{"key":"10.1016\/j.remn.2016.11.005_bib0255","first-page":"92","article-title":"Pharmacokinetics and radiation dosimetry of 18F-fluorocholine","volume":"43","author":"DeGrado","year":"2002","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2016.11.005_bib0260","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.remn.2016.11.005_bib0265","first-page":"1805","article-title":"Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers","volume":"42","author":"DeGrado","year":"2001","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2016.11.005_bib0270","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1552-6569.2004.tb00253.x","article-title":"Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation","volume":"14","author":"Kwee","year":"2004","journal-title":"J Neuroimaging."},{"key":"10.1016\/j.remn.2016.11.005_bib0275","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/RLU.0b013e3182336100","article-title":"F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas","volume":"37","author":"Roelcke","year":"2012","journal-title":"Clin Nucl Med."},{"key":"10.1016\/j.remn.2016.11.005_bib0280","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3174\/ajnr.A1008","article-title":"Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography","volume":"29","author":"Kato","year":"2008","journal-title":"AJNR Am J Neuroradiol."},{"key":"10.1016\/j.remn.2016.11.005_bib0285","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1148\/radiol.2442060898","article-title":"Solitary brain lesions enhancing at MR imaging: Evaluation with fluorine 18 fluorocholine PET","volume":"244","author":"Kwee","year":"2007","journal-title":"Radiology."},{"key":"10.1016\/j.remn.2016.11.005_bib0290","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clineuro.2010.09.012","article-title":"Promising role of [18F] fluorocholine PET\/CT vs [18F] fluorodeoxyglucose PET\/CT in primary brain tumors-early experience","volume":"113","author":"Lam","year":"2011","journal-title":"Clin Neurol Neurosurg."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X1630172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X1630172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T07:22:48Z","timestamp":1536045768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X1630172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2253654X1630172X"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2016.11.005","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valor de la PET\/TC cerebral con 18F-fluorocolina en la detecci\u00f3n de recurrencias de neoplasias primarias del sistema nervioso central","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2016.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. y SEMNIM. All rights reserved.","name":"copyright","label":"Copyright"}]}}